These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 31364274)
1. Comparison of real world and core laboratory lupus anticoagulant results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) clinical database and repository. Efthymiou M; Mackie IJ; Lane PJ; Andrade D; Willis R; Erkan D; Sciascia S; Krillis S; Bison E; Borges Galhardo Vendramini M; Romay-Penabad Z; Qi M; Tektonidou M; Ugarte A; Chighizola C; Belmont HM; Aguirre MA; Ji L; Branch DW; de Jesus G; Fortin PR; Andreoli L; Petri M; Cervera R; Rodriguez E; Knight JS; Atsumi T; Vega J; Sevim E; Bertolaccini ML; Pengo V; Cohen H; J Thromb Haemost; 2019 Dec; 17(12):2069-2080. PubMed ID: 31364274 [TBL] [Abstract][Full Text] [Related]
2. The comparison of real world and core laboratory antiphospholipid antibody ELISA results from antiphospholipid syndrome alliance for clinical trials & international networking (APS ACTION) clinical database and repository analysis. Sciascia S; Willis R; Pengo V; Krilis S; Andrade D; Tektonidou MG; Ugarte A; Chighizola C; Branch DW; Levy RA; Nalli C; Fortin PR; Petri M; Rodriguez E; Rodriguez-Pinto I; Atsumi T; Nascimento I; Rosa R; Banzato A; Erkan D; Cohen H; Efthymiou M; Mackie I; Bertolaccini ML; Thromb Res; 2019 Mar; 175():32-36. PubMed ID: 30685523 [TBL] [Abstract][Full Text] [Related]
3. Interactions between rivaroxaban and antiphospholipid antibodies in thrombotic antiphospholipid syndrome. Arachchillage DR; Mackie IJ; Efthymiou M; Isenberg DA; Machin SJ; Cohen H J Thromb Haemost; 2015 Jul; 13(7):1264-73. PubMed ID: 25850997 [TBL] [Abstract][Full Text] [Related]
4. International multicenter, multiplatform study to validate Taipan snake venom time as a lupus anticoagulant screening test with ecarin time as the confirmatory test: Communication from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies. Moore GW; Jones PO; Platton S; Hussain N; White D; Thomas W; Rigano J; Pouplard C; Gray E; Devreese KMJ J Thromb Haemost; 2021 Dec; 19(12):3177-3192. PubMed ID: 34192404 [TBL] [Abstract][Full Text] [Related]
5. Reliability of Lupus Anticoagulant and Anti-phosphatidylserine/prothrombin Autoantibodies in Antiphospholipid Syndrome: A Multicenter Study. Sciascia S; Radin M; Cecchi I; Rubini E; Scotta A; Rolla R; Montaruli B; Pergolini P; Mengozzi G; Muccini E; Baldovino S; Ferro M; Vaccarino A; Mahler M; Menegatti E; Roccatello D Front Immunol; 2019; 10():376. PubMed ID: 30891041 [No Abstract] [Full Text] [Related]
6. Laboratory diagnosis of lupus anticoagulants for patients on oral anticoagulant treatment. Performance of dilute Russell viper venom test and silica clotting time in comparison with Staclot LA. Tripodi A; Chantarangkul V; Clerici M; Mannucci PM Thromb Haemost; 2002 Oct; 88(4):583-6. PubMed ID: 12362227 [TBL] [Abstract][Full Text] [Related]
8. The effect of DOAC-Stop on lupus anticoagulant testing in plasma samples of venous thromboembolism patients receiving direct oral anticoagulants. Ząbczyk M; Kopytek M; Natorska J; Undas A Clin Chem Lab Med; 2019 Aug; 57(9):1374-1381. PubMed ID: 30763261 [TBL] [Abstract][Full Text] [Related]
9. Paired APTTs of low and high lupus anticoagulant sensitivity permit distinction from other abnormalities and achieve good lupus anticoagulant detection rates in conjunction with dRVVT. Kumano O; Amiral J; Dunois C; Peyrafitte M; Moore GW Int J Lab Hematol; 2019 Feb; 41(1):60-68. PubMed ID: 30248243 [TBL] [Abstract][Full Text] [Related]
10. Taipan snake venom time has high sensitivity for lupus anticoagulants in non-anticoagulated, triple positive antiphospholipid syndrome patients. Moore GW; Platton S; Yartey N; Foxton E; White D; MacDonald SG Int J Lab Hematol; 2024 Jun; 46(3):538-545. PubMed ID: 38303489 [TBL] [Abstract][Full Text] [Related]
11. Newly developed dilute Russell's viper venom reagents for lupus anticoagulant detection with improved specificity. Moore GW; Peyrafitte M; Dunois C; Amiral J Lupus; 2018 Jan; 27(1):95-104. PubMed ID: 28549386 [TBL] [Abstract][Full Text] [Related]
12. Screening for lupus anticoagulants in patients treated with vitamin K antagonists. Isert M; Miesbach W; Stoever G; Lindhoff-Last E; Linnemann B Int J Lab Hematol; 2015 Dec; 37(6):758-65. PubMed ID: 26224222 [TBL] [Abstract][Full Text] [Related]
13. Clinical and laboratory characteristics of Brazilian versus non-Brazilian primary antiphospholipid syndrome patients in AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) clinical database and repository. de Azevedo Lopes E; Balbi GGM; Tektonidou MG; Pengo V; Sciascia S; Ugarte A; Belmont HM; Gerosa M; Fortin PR; Lopez-Pedrera C; Ji L; Cohen H; de Jesús GR; Branch DW; Nalli C; Petri M; Rodriguez E; Kello N; Ríos-Garcés R; Knight JS; Atsumi T; Willis R; Bertolaccini ML; Erkan D; Andrade D; Adv Rheumatol; 2021 Oct; 61(1):64. PubMed ID: 34711275 [TBL] [Abstract][Full Text] [Related]
14. Variability of cut-off values for the detection of lupus anticoagulants: results of an international multicenter multiplatform study. Tripodi A; Chantarangkul V; Cini M; Devreese K; Dlott JS; Giacomello R; Gray E; Legnani C; Martinuzzo ME; Pradella P; Siegemund A; Subramanian S; Suchon P; Testa S J Thromb Haemost; 2017 Jun; 15(6):1180-1190. PubMed ID: 28316135 [TBL] [Abstract][Full Text] [Related]
15. Viewpoint: Lupus anticoagulant detection and interpretation in antiphospholipid syndrome. Efthymiou M; Bertolaccini ML; Cohen H Rheumatology (Oxford); 2024 Feb; 63(SI):SI54-SI63. PubMed ID: 38320587 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic accuracy of silica clotting time method for lupus anticoagulant in a clinical population with various symptoms of antiphospholipid syndrome. Averina M; Johannesen S; Brox J Lupus; 2016 Apr; 25(4):418-22. PubMed ID: 26612052 [TBL] [Abstract][Full Text] [Related]